Macom SVP global sales Hwang sells over $1m in stock

INVESTING.COMMay 4, 8:52 PM UTC

Key insights

  • MACOM SVP of Global Sales sold over $1M in stock near 52-week highs under a pre-arranged plan. The stock appears overvalued according to some analysis. Recent earnings beat expectations, leading to price target increases from Benchmark and Stifel. Bank of America highlighted Marvell Technology as a key beneficiary in the optical sector. The insider selling and overvaluation concerns slightly offset the positive earnings news.
Macom SVP global sales Hwang sells over $1m in stock

Hwang Donghyun Thomas, Senior Vice President of Global Sales at MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI), sold 3,718 shares of the company’s common stock on April 30, 2026. The transactions amounted to a total value of $1,028,916.

The shares were sold at prices ranging from $271.40 to $281.59 per share. These sales were executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Hwang on August 11, 2025.The insider sale comes as MTSI stock trades near its 52-week high of $294.00, reflecting a remarkable 153% gain over the past year. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, placing it among the most overvalued stocks in the market. The company reports earnings on May 7, just three days away. For deeper insights, investors can access MTSI’s comprehensive Pro Research Report, available for this and 1,400+ other US equities.

Following these transactions, Mr. Hwang directly holds 34,886 shares of MACOM Technology Solutions Holdings common stock.

In other recent news, MACOM Technology Solutions reported impressive earnings for the first quarter of fiscal year 2026, surpassing both revenue and earnings per share forecasts. The company achieved an adjusted EPS of $1.02, exceeding the anticipated $0.9973, while revenue reached $271.6 million, surpassing the expected $269.02 million. This strong performance was accompanied by a 4.0% sequential increase and a 24.5% year-over-year growth in sales, which exceeded the company’s guidance midpoint and analyst estimates. Following these results, Benchmark raised its price target for MACOM Technology to $260 from $190, maintaining a Buy rating, while Stifel increased its target to $255 from $215, also with a Buy rating. Both firms expressed confidence in the company’s growth prospects, noting a record backlog and a healthy book-to-bill ratio of 1.3. Meanwhile, Bank of America highlighted Marvell Technology as a key beneficiary in the optical networking sector, driven by strong demand and the transition to 1.6T technology. These developments reflect a positive outlook for MACOM Technology and Marvell Technology amid evolving market conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Continue reading on INVESTING.COM

Related Articles